Ureter Carcinoma clinical trials at UC Health
1 in progress, 0 open to eligible people
Sorry, currently not accepting new patients, but might later
The purpose of the ATLAS study is to determine how patients with locally advanced unresectable or metastatic urothelial carcinoma respond to treatment with rucaparib.
at UCLA UCSD